347 related articles for article (PubMed ID: 30187864)
21. Study of the efficacy, tolerability, and safety of 2 fixed-dose combination gels in the management of acne vulgaris.
Zouboulis CC; Fischer TC; Wohlrab J; Barnard J; Alió AB
Cutis; 2009 Oct; 84(4):223-9. PubMed ID: 19911678
[TBL] [Abstract][Full Text] [Related]
22. The efficacy, safety and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris; a randomized trial.
Babaeinejad SH; Fouladi RF
J Drugs Dermatol; 2013 Sep; 12(9):1033-8. PubMed ID: 24002152
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and Safety of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Oral Doxycycline in Subjects With Severe Inflammatory Acne Who Are Candidates for Oral Isotretinoin.
Del Rosso JQ; Stein Gold L; Johnson SM; Rueda MJ; Baldwin H; Lain EL; Landis M; Rendon M; Tanghetti E; Weiss J
J Drugs Dermatol; 2018 Mar; 17(3):264-273. PubMed ID: 29537444
[TBL] [Abstract][Full Text] [Related]
24. Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial.
Capizzi R; Landi F; Milani M; Amerio P
Br J Dermatol; 2004 Aug; 151(2):481-4. PubMed ID: 15327558
[TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
Eichenfield LF; Alió Sáenz AB
J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
[TBL] [Abstract][Full Text] [Related]
26. Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study.
Guerra-Tapia A
J Drugs Dermatol; 2012 Jun; 11(6):714-22. PubMed ID: 22648218
[TBL] [Abstract][Full Text] [Related]
27. Multicenter study for efficacy and safety evaluation of a fixeddose combination gel with adapalen 0.1% and benzoyl peroxide 2.5% (Epiduo® for the treatment of acne vulgaris in Brazilian population.
Sittart JA; Costa Ad; Mulinari-Brenner F; Follador I; Azulay-Abulafia L; Castro LC
An Bras Dermatol; 2015 Dec; 90(6 Suppl 1):1-16. PubMed ID: 27168522
[TBL] [Abstract][Full Text] [Related]
28. The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions.
Feldman SR; Tan J; Poulin Y; Dirschka T; Kerrouche N; Manna V
J Am Acad Dermatol; 2011 Jun; 64(6):1085-91. PubMed ID: 21439678
[TBL] [Abstract][Full Text] [Related]
29. Treatment of 2,453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl peroxide combination topical gel: efficacy and safety.
Eichenfield LE; Jorizzo JL; Dirschka T; Taub AF; Lynde C; Graeber M; Kerrouche N
J Drugs Dermatol; 2010 Nov; 9(11):1395-401. PubMed ID: 21061762
[TBL] [Abstract][Full Text] [Related]
30. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
Langner A; Chu A; Goulden V; Ambroziak M
Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
[TBL] [Abstract][Full Text] [Related]
31. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years.
Keating GM
Am J Clin Dermatol; 2011 Dec; 12(6):407-20. PubMed ID: 21967116
[TBL] [Abstract][Full Text] [Related]
32. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
Draelos ZD; Potts A; Alió Saenz AB;
Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
[TBL] [Abstract][Full Text] [Related]
33. Randomized, observer-blind, split-face study to compare the irritation potential of 2 topical acne formulations over a 14-day treatment period.
Ting W
Cutis; 2012 Aug; 90(2):91-6. PubMed ID: 22988653
[TBL] [Abstract][Full Text] [Related]
34. Adapalene 0.1%/benzoyl peroxide 2.5% gel reduces the risk of atrophic scar formation in moderate inflammatory acne: a split-face randomized controlled trial.
Dreno B; Tan J; Rivier M; Martel P; Bissonnette R
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):737-742. PubMed ID: 27790756
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.
Stein Gold L; Baldwin H; Kircik LH; Weiss JS; Pariser DM; Callender V; Lain E; Gold M; Beer K; Draelos Z; Sadick N; Pillai R; Bhatt V; Tanghetti EA
Am J Clin Dermatol; 2022 Jan; 23(1):93-104. PubMed ID: 34674160
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of adapalene 0.1% / benzoyl peroxide 2.5% in the long-term treatment of predominantly moderate acne with or without concomitant medication - results from the non-interventional cohort study ELANG.
Gollnick HP; Friedrich M; Peschen M; Pettker R; Pier A; Streit V; Jöstingmeyer P; Porombka D; Rojo Pulido I; Jäckel A
J Eur Acad Dermatol Venereol; 2015 Jun; 29 Suppl 4():15-22. PubMed ID: 26059730
[TBL] [Abstract][Full Text] [Related]
37. A multicentre, randomized, single-blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once-daily gel versus clindamycin 1% twice-daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients.
Xu JH; Lu QJ; Huang JH; Hao F; Sun QN; Fang H; Gu J; Dong XQ; Zheng J; Luo D; Li FQ; Wang G; Gu H; Tian HQ; Yang HL; Xi LY; Li M; Zheng M; Wu Y; Tu YT; He YL; Zhao G; Sheng WX; Li J; Hamedani AG
J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1176-82. PubMed ID: 27075705
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of adapalene/benzoyl peroxide combination in moderate inflammatory acne and its impact on patient adherence.
Gollnick HP; Funke G; Kors C; Titzmann T; Jöstingmeyer P; Jäckel A
J Dtsch Dermatol Ges; 2015 Jun; 13(6):557-65. PubMed ID: 26018369
[TBL] [Abstract][Full Text] [Related]
39. How to Increase Adherence and Compliance in Acne Treatment? A Combined Strategy of SMS and Visual Instruction Leaflet.
Donnarumma M; Fattore D; Greco V; Ferrillo M; Vastarella M; Chiodini P; Fabbrocini G
Dermatology; 2019; 235(6):463-470. PubMed ID: 31586999
[TBL] [Abstract][Full Text] [Related]
40. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study.
Thiboutot DM; Weiss J; Bucko A; Eichenfield L; Jones T; Clark S; Liu Y; Graeber M; Kang S;
J Am Acad Dermatol; 2007 Nov; 57(5):791-9. PubMed ID: 17655969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
